pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

Patterns of acute and preventive therapy in patients eligible for migraine prophylaxis

N Drug utilization (%)
Drug for acute therapy 534 100.0
Sumatriptan 155 29.0
Ergotamine 146 27.3
Naratriptan 102 19.1
Almotriptan 54 10.1
Zolmitriptan 47 8.8
Frovatriptan 30 5.6
Drug for preventive therapy 234 100.0
Propranolol 82 35.0
Flunarizine 76 32.5
Topiramate 32 13.7
Amitriptyline 30 12.8
Valproic acid/valproate/divalproex 9 3.8
Nadolol 5 2.1
Drug class of preventive therapy 234 100.0
Beta-blockers 87 37.2
Calcium channel blockers 76 32.5
Anticonvulsants 41 17.5
Antidepressants 30 12.8
Korean J Clin Pharm 2021;31:35-43 https://doi.org/10.24304/kjcp.2021.31.1.35
© 2021 Korean J Clin Pharm